Russian Contacts Sitemap

For Patients & Their Families For Doctors & Healthcare Professionals For R&D-Center Clients

For Payers & Insurers For Suppliers Business Development Solutions & Opportunities

Home R&D-Center About R&D-Center NovaMedica Innotech Conclusion on the Conformity of the Manufacturer of Drug Products for Medical Use with the Good Manufacturing Practices (GMP)

Conclusion on the Conformity of the Manufacturer of Drug Products for Medical Use with the Good Manufacturing Practices (GMP)

Shareholders

Pipeline

Media Center

WHO Endorses Protocol for COVID-19 Herbal Medicine Clinical Trials

23 September 2020
Coronavir to Become the First COVID-19 Medicine Available in Pharmacies

23 September 2020
FAS Russia: Our Task is to Create Necessary Conditions for Ensuring Patients’ Access to Innovative Medicines

22 September 2020
Favipiravir in Russia Received Permission for Outpatient Use

22 September 2020